Meridian Bioscience

Meridian Bioscience Tax Rate

The Effective Tax Rate of Meridian Bioscience (VIVO) as of Oct 27, 2026 is 21.83 %. In the previous year, Effective Tax Rate was 21.05 % — a change of 3.69% (higher).

Tax Rate

21.83 %

YoY

3.69%

Last updated:

Effective Tax Rate of Meridian Bioscience is 2022 21.83 % . Effective Tax Rate of Meridian Bioscience was 2021 21.05 % . It decreases by 3.69% higher compared to the previous year.

The Meridian Bioscience Tax Rate history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Rate
Date
Tax Rate
Jan 1, 2015
35.39 USD
Jan 1, 2016
36.36 USD
Jan 1, 2017
40.93 USD
Jan 1, 2018
27.30 USD
Jan 1, 2019
22.78 USD
Jan 1, 2020
22.09 USD
Jan 1, 2021
21.05 USD
Jan 1, 2022
21.83 USD
The Meridian Bioscience Tax Rate history
YEARTax RateYoY
21.83 %+3.69%
21.05 %-4.69%
22.09 %-3.04%
22.78 %-16.55%
27.30 %-33.30%
40.93 %+12.57%
36.36 %+2.75%
35.39 %+5.97%
33.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Effective Tax Rate of Meridian Bioscience is 21.83 % in 2022.

Effective Tax Rate of Meridian Bioscience changed from 21.05 % to 21.83 %, representing a 3.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Effective Tax Rate Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

The effective tax rate measures the actual percentage of pretax income paid in taxes. It reflects the company's tax efficiency and planning.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Effective Tax Rate's Meridian Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Effective Tax Rate's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Effective Tax Rate.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Meridian Bioscience

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Meridian Bioscience